HIV Combination prevention: Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia (2018 progress report)
HIV combination prevention is an approach that brings together single prevention initiatives into a comprehensive programme. This approach considers that the offer of multiple evidence-based interventions in a comprehensive programme will have a greater impact on HIV transmission than investing in a single strategy. In this report we
present and test the feasibility of a novel approach to monitoring the implementation of combination HIV prevention at national level.
Spring European Testing Week 2020
European Testing Week is a European campaign that encourages partner organisations, in community, health care and policy institutions, throughout Europe to unite for one week twice a year to increase testing efforts and promote awareness on the benefits of earlier hepatitis and HIV testing.
Guidance on HPV vaccination in EU countries: focus on boys, people living with HIV and 9-valent HPV vaccine introduction
This document summarises evidence from studies included in the licensing file of HPV vaccines together with postlicensure, peer-reviewed data and analysis where available. This guidance does not address the safety of HPV vaccines observed during the pre- and post-licensing period.
HIV and men who have sex with men - Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia: 2018 progress report
This report is part of the 2018 progress reports monitoring the implementation of the Dublin Declaration. It presents the situation among men who have sex with men (MSM), a key group affected by HIV in the WHO European Region, and outlines priorities for action.
The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union/European Economic Area
Cole, M.J., Quinten, C., Jacobsson, S., Day, M., Amato-Gauci, A.J., Woodford, N., Spiteri, G., Unemo, M., Stary, A., Haller, M., Verbrugge, R., Crucitti, T., Soteriou, S., Pieridou, D., Cowan, S., Hoffmann, S., Epstein, J., Viktorova, J., Ndeikoundam, N., Goubard, A., Kohl, P., Buder, S., Bremer, V., Tzelepi, E., Konte, V., Balla, E., Dudás, M., Sigmundsdóttir, G., Hauksdóttir, G.S., Igoe, D., Crowley, B., Suligoi, B., Stefanelli, P., Pakarna, G., Mavcutko, V., Barbara, C., Melillo, J.M., Van Dam, A., Van Benthem, B., Linde, I., Kløvstad, H., Bergheim, T., Majewski, S., Mlynarczyk-Bonikowska, B., Azevedo, J., Borrego, M.J., Pavlik, P., Truska, P., Klavs, I., Jeverica, S., Vazquez, J., Diez, M., Velicko, I., Unemo, M., Hughes, G., Eastick, K.
Reorienting health systems to care for people with HIV beyond viral suppression
Safreed-Harmon, K., Anderson, J., Azzopardi-Muscat, N., Behrens, G.M.N., d'Arminio Monforte, A., Davidovich, U., del Amo, J., Kall, M., Noori, T., Porter, K., Lazarus, J.V.
Half of all women with HIV are diagnosed late in Europe
Many women in the WHO European Region, particularly those in their 40s, are diagnosed at a late stage of HIV infection when their immune system is already starting to fail. They are three to four times more likely to be diagnosed late than younger women. According to data for 2018 released today by the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe, women accounted for one-third of the 141 000 new HIV diagnoses in the Region, indicating that this population needs more attention in Europe's prevention and testing efforts.
Infographic: HIV late Diagnosis - 2018 data
In the EU/EEA, almost every second HIV diagnosis happened at a late stage in 2018. This means diagnosis several years after infection. In 2018, 49 % of those with a CD4 cell count reported at HIV diagnosis were diagnosed late (several years after infection).